| Product NDC: | 55648-554 |
| Proprietary Name: | RISPERIDONE |
| Non Proprietary Name: | RISPERIDONE |
| Active Ingredient(s): | .5 mg/1 & nbsp; RISPERIDONE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55648-554 |
| Labeler Name: | WOCKHARDT LIMITED |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078871 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20081009 |
| Package NDC: | 55648-554-03 |
| Package Description: | 100 BLISTER PACK in 1 CARTON (55648-554-03) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
| NDC Code | 55648-554-03 |
| Proprietary Name | RISPERIDONE |
| Package Description | 100 BLISTER PACK in 1 CARTON (55648-554-03) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 55648-554 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | RISPERIDONE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20081009 |
| Marketing Category Name | ANDA |
| Labeler Name | WOCKHARDT LIMITED |
| Substance Name | RISPERIDONE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |